Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel

Transcription

1 Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel David T. Kuhar, M.D. Medical Epidemiologist HICPAC Meeting June 6, 2013 National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion, Prevention and Response Branch

2 Outline Update Plan Current Status Planning and Prioritizing Section II: Specific Infectious Diseases Need HICPAC input

3 Update Plan Reminiscent of the previous 1998 Guideline Objective: Recommendations for reducing the transmission of infections from patients to HCP and from HCP to patients Primary Audiences: Occupational Health and Infection Prevention and Control Departments 3 Main Sections: I. Baseline Infrastructure and Routine Practices II. III. Objectives, medical evaluations, personnel education, etc. Specific Infectious Diseases 1998 Guideline covered over 22 infectious conditions Special HCP populations Pregnancy, immunocompromised, travelling HCP, etc.

4 Update Plan Avoid duplication with other CDC guidelines Link and reference other guidelines Immunizations Norovirus Bloodborne pathogens TB Others

5 Current Status Section I: Baseline Infrastructure and Routine Practices Core Writing Group David Kuhar Amanda Overholt Mark Russi Tammy Lundstrom Ruth Carrico External Expert Group being finalized Semimonthly conference calls Systematic literature search strategy development Draft in progress

6 Section II Specific Infectious Diseases Bloodborne Pathogens HIV HBV HCV Conjunctivitis CMV Disease Diphtheria GI Infections, Acute Norovirus C. difficile Others Hepatitis A Herpes Simplex Measles Meningococcal Disease Multidrug-Resistant Gram Negative Bacteria Mumps Parvovirus Pertussis Poliomyelitis Rabies Rubella Scabies and Pediculosis Staphylococcus aureus MSSA MRSA Group A Streptococcus Tuberculosis Vaccinia Varicella Viral Respiratory Infections Influenza RSV Others Potential Agents of Bioterrorism

7 Section II Specific Infectious Diseases Bloodborne Pathogens HIV HBV *HCV Conjunctivitis CMV Disease Diphtheria GI Infections, Acute Norovirus *C. difficile Others Hepatitis A Herpes Simplex Measles Meningococcal Disease Multidrug-Resistant Gram Negative Bacteria Mumps Parvovirus *Pertussis Poliomyelitis Rabies Rubella Scabies and Pediculosis Staphylococcus Aureus MSSA *MRSA *Group A Streptococcus Tuberculosis Vaccinia Varicella Viral Respiratory Infections Influenza RSV Others Potential Agents of Bioterrorism

8 Hepatitis C Treatment of acute hepatitis C Best practices for monitoring HCP who were exposed to hepatitis C antibody +, RNA blood

9 Clostridium difficile Risk of developing C. difficile infection in exposed HCP Duration of work restrictions for infected personnel

10 Pertussis Best method for monitoring exposed HCP for signs of pertussis Most effective test(s) in diagnosing pertussis

11 MRSA Screening HCP for colonization Absent an MRSA outbreak HCP linked to an outbreak Actions based on results Decolonization Work restrictions Criteria to establish successful decolonization of HCP Work restrictions for HCP with infections

12 GAS in HCP Circumstances for screening HCP for GAS colonization Indications for post-exposure prophylaxis Duration of work restrictions for HCP linked to an outbreak

13 Thank you! For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA Telephone: CDC-INFO ( )/TTY: Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion, Prevention and Response Branch

14 Section II Specific Infectious Diseases Bloodborne Pathogens HIV HBV *HCV Conjunctivitis CMV Disease Diphtheria GI Infections, Acute Norovirus *C. difficile Others Hepatitis A Herpes Simplex Measles Meningococcal Disease Multidrug-Resistant Gram Negative Bacteria Mumps Parvovirus *Pertussis Poliomyelitis Rabies Rubella Scabies and Pediculosis Staphylococcus Aureus MSSA *MRSA *Group A Streptococcus Tuberculosis Vaccinia Varicella Viral Respiratory Infections Influenza RSV Others Potential Agents of Bioterrorism